United States Prostacyclin Market Report 2017

February 2017 | 104 pages | ID: U4BBEF68C85EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Prostacyclin

Revenue, means the sales value of Prostacyclin

This report studies sales (consumption) of Prostacyclin in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Actelion Pharmaceuticals
• United Therapeutics Corporation
• Gilead
• Bayer AG
• SteadyMed
• GlaxoSmithKline
• Pfizer
• Reata Pharmaceuticals
• Arena Pharmaceuticals
• Merck

Market Segment by States, covering

• California
• Texas
• New York
• Florida
• Illinois

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II

Split by applications, this report focuses on sales, market share and growth rate of Prostacyclin in each application, can be divided into

• Application 1
• Application 2

Contents

United States Prostacyclin Market Report 2017

1 PROSTACYCLIN OVERVIEW

1.1 Product Overview and Scope of Prostacyclin
1.2 Classification of Prostacyclin
  1.2.1 Type I
  1.2.2 Type II
1.3 Application of Prostacyclin
  1.3.1 Application
  1.3.2 Application
1.4 United States Market Size Sales (Volume) and Revenue (Value) of Prostacyclin (2012-2022)
  1.4.1 United States Prostacyclin Sales and Growth Rate (2012-2022)
  1.4.2 United States Prostacyclin Revenue and Growth Rate (2012-2022)

2 UNITED STATES PROSTACYCLIN COMPETITION BY MANUFACTURERS

2.1 United States Prostacyclin Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Prostacyclin Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Prostacyclin Average Price by Manufactures (2015 and 2016)
2.4 Prostacyclin Market Competitive Situation and Trends
  2.4.1 Prostacyclin Market Concentration Rate
  2.4.2 Prostacyclin Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES PROSTACYCLIN SALES (VOLUME) AND REVENUE (VALUE) BY STATES (2012-2017)

3.1 United States Prostacyclin Sales and Market Share by States (2012-2017)
3.2 United States Prostacyclin Revenue and Market Share by States (2012-2017)
3.3 United States Prostacyclin Price by States (2012-2017)

4 UNITED STATES PROSTACYCLIN SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2012-2017)

4.1 United States Prostacyclin Sales and Market Share by Type (2012-2017)
4.2 United States Prostacyclin Revenue and Market Share by Type (2012-2017)
4.3 United States Prostacyclin Price by Type (2012-2017)
4.4 United States Prostacyclin Sales Growth Rate by Type (2012-2017)

5 UNITED STATES PROSTACYCLIN SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Prostacyclin Sales and Market Share by Application (2012-2017)
5.2 United States Prostacyclin Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES PROSTACYCLIN MANUFACTURERS PROFILES/ANALYSIS

6.1 Actelion Pharmaceuticals
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Prostacyclin Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Actelion Pharmaceuticals Prostacyclin Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 United Therapeutics Corporation
  6.2.2 Prostacyclin Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 United Therapeutics Corporation Prostacyclin Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Gilead
  6.3.2 Prostacyclin Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Gilead Prostacyclin Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Bayer AG
  6.4.2 Prostacyclin Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Bayer AG Prostacyclin Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 SteadyMed
  6.5.2 Prostacyclin Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 SteadyMed Prostacyclin Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 GlaxoSmithKline
  6.6.2 Prostacyclin Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 GlaxoSmithKline Prostacyclin Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Pfizer
  6.7.2 Prostacyclin Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Pfizer Prostacyclin Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Reata Pharmaceuticals
  6.8.2 Prostacyclin Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Reata Pharmaceuticals Prostacyclin Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Arena Pharmaceuticals
  6.9.2 Prostacyclin Product Type, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Arena Pharmaceuticals Prostacyclin Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Merck
  6.10.2 Prostacyclin Product Type, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Merck Prostacyclin Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview

7 PROSTACYCLIN MANUFACTURING COST ANALYSIS

7.1 Prostacyclin Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Prostacyclin

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Prostacyclin Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Prostacyclin Major Manufacturers in 2015
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES PROSTACYCLIN MARKET FORECAST (2017-2022)

11.1 United States Prostacyclin Sales, Revenue Forecast (2017-2022)
11.2 United States Prostacyclin Sales Forecast by Type (2017-2022)
11.3 United States Prostacyclin Sales Forecast by Application (2017-2022)
11.4 Prostacyclin Price Forecast (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Prostacyclin
Table Classification of Prostacyclin
Figure United States Sales Market Share of Prostacyclin by Type in 2015
Table Application of Prostacyclin
Figure United States Sales Market Share of Prostacyclin by Application in 2015
Figure United States Prostacyclin Sales and Growth Rate (2012-2022)
Figure United States Prostacyclin Revenue and Growth Rate (2012-2022)
Table United States Prostacyclin Sales of Key Manufacturers (2015 and 2016)
Table United States Prostacyclin Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Prostacyclin Sales Share by Manufacturers
Figure 2016 Prostacyclin Sales Share by Manufacturers
Table United States Prostacyclin Revenue by Manufacturers (2015 and 2016)
Table United States Prostacyclin Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Prostacyclin Revenue Share by Manufacturers
Table 2016 United States Prostacyclin Revenue Share by Manufacturers
Table United States Market Prostacyclin Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Prostacyclin Average Price of Key Manufacturers in 2015
Figure Prostacyclin Market Share of Top 3 Manufacturers
Figure Prostacyclin Market Share of Top 5 Manufacturers
Table United States Prostacyclin Sales by States (2012-2017)
Table United States Prostacyclin Sales Share by States (2012-2017)
Figure United States Prostacyclin Sales Market Share by States in 2015
Table United States Prostacyclin Revenue and Market Share by States (2012-2017)
Table United States Prostacyclin Revenue Share by States (2012-2017)
Figure Revenue Market Share of Prostacyclin by States (2012-2017)
Table United States Prostacyclin Price by States (2012-2017)
Table United States Prostacyclin Sales by Type (2012-2017)
Table United States Prostacyclin Sales Share by Type (2012-2017)
Figure United States Prostacyclin Sales Market Share by Type in 2015
Table United States Prostacyclin Revenue and Market Share by Type (2012-2017)
Table United States Prostacyclin Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Prostacyclin by Type (2012-2017)
Table United States Prostacyclin Price by Type (2012-2017)
Figure United States Prostacyclin Sales Growth Rate by Type (2012-2017)
Table United States Prostacyclin Sales by Application (2012-2017)
Table United States Prostacyclin Sales Market Share by Application (2012-2017)
Figure United States Prostacyclin Sales Market Share by Application in 2015
Table United States Prostacyclin Sales Growth Rate by Application (2012-2017)
Figure United States Prostacyclin Sales Growth Rate by Application (2012-2017)
Table Actelion Pharmaceuticals Basic Information List
Table Actelion Pharmaceuticals Prostacyclin Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Actelion Pharmaceuticals Prostacyclin Sales Market Share (2012-2017)
Table United Therapeutics Corporation Basic Information List
Table United Therapeutics Corporation Prostacyclin Sales, Revenue, Price and Gross Margin (2012-2017)
Table United Therapeutics Corporation Prostacyclin Sales Market Share (2012-2017)
Table Gilead Basic Information List
Table Gilead Prostacyclin Sales, Revenue, Price and Gross Margin (2012-2017)
Table Gilead Prostacyclin Sales Market Share (2012-2017)
Table Bayer AG Basic Information List
Table Bayer AG Prostacyclin Sales, Revenue, Price and Gross Margin (2012-2017)
Table Bayer AG Prostacyclin Sales Market Share (2012-2017)
Table SteadyMed Basic Information List
Table SteadyMed Prostacyclin Sales, Revenue, Price and Gross Margin (2012-2017)
Table SteadyMed Prostacyclin Sales Market Share (2012-2017)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Prostacyclin Sales, Revenue, Price and Gross Margin (2012-2017)
Table GlaxoSmithKline Prostacyclin Sales Market Share (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Prostacyclin Sales, Revenue, Price and Gross Margin (2012-2017)
Table Pfizer Prostacyclin Sales Market Share (2012-2017)
Table Reata Pharmaceuticals Basic Information List
Table Reata Pharmaceuticals Prostacyclin Sales, Revenue, Price and Gross Margin (2012-2017)
Table Reata Pharmaceuticals Prostacyclin Sales Market Share (2012-2017)
Table Arena Pharmaceuticals Basic Information List
Table Arena Pharmaceuticals Prostacyclin Sales, Revenue, Price and Gross Margin (2012-2017)
Table Arena Pharmaceuticals Prostacyclin Sales Market Share (2012-2017)
Table Merck Basic Information List
Table Merck Prostacyclin Sales, Revenue, Price and Gross Margin (2012-2017)
Table Merck Prostacyclin Sales Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Prostacyclin
Figure Manufacturing Process Analysis of Prostacyclin
Figure Prostacyclin Industrial Chain Analysis
Table Raw Materials Sources of Prostacyclin Major Manufacturers in 2015
Table Major Buyers of Prostacyclin
Table Distributors/Traders List
Figure United States Prostacyclin Production and Growth Rate Forecast (2017-2022)
Figure United States Prostacyclin Revenue and Growth Rate Forecast (2017-2022)
Table United States Prostacyclin Production Forecast by Type (2017-2022)
Table United States Prostacyclin Consumption Forecast by Application (2017-2022)
Table United States Prostacyclin Sales Forecast by States (2017-2022)
Table United States Prostacyclin Sales Share Forecast by States (2017-2022)